Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

113
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating MYOM3 fragments reflect disease severity and therapeutic efficacy in tubular aggregate myopathy and Stormorken syndrome.

Human molecular genetics·2026
Same author

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.

The Lancet. Child & adolescent health·2026
Same author

Bilateral perifoveal macular ischemia in non-proliferative Duchenne muscular dystrophy-associated retinopathy: a case report.

Documenta ophthalmologica. Advances in ophthalmology·2026
Same author

Rhabdomyolysis: a narrative review.

Arquivos de neuro-psiquiatria·2026
Same author

The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single <i>SMN2</i> copy: an international retrospective observational study.

EClinicalMedicine·2026
Same author

Adaptive and degenerative remodeling of the diaphragm in patients with interstitial lung disease: A cross-sectional study.

Respiratory physiology & neurobiology·2026

Related Experiment Video

Updated: Apr 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K

Integrative data mining highlights candidate genes for monogenic myopathies.

Osorio Abath Neto1, Olivier Tassy2, Valérie Biancalana3

  • 1Dept. of Translational Medicine and Neurogenetics, IGBMC, INSERM U964, CNRS UMR7104, University of Strasbourg, Collège de France, Illkirch, Strasbourg, France; Departamento de Neurologia, Faculdade de Medicina de São Paulo (FMUSP), São Paulo, Brazil.

Plos One
|October 30, 2014
PubMed
Summary

This study introduces a data mining strategy to identify and rank candidate genes for inherited myopathies, aiding in molecular diagnoses for undiagnosed patients. The approach prioritizes genes by analyzing genetic networks and disease signatures, improving genetic discovery in rare diseases.

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

22.2K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Related Experiment Videos

Last Updated: Apr 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

9.2K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

22.2K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Computational Biology

Background:

  • Inherited myopathies are diverse genetic disorders with poorly understood mechanisms, leaving ~40% of patients undiagnosed.
  • High-throughput sequencing offers potential for new gene discovery, but requires prioritized candidate gene lists for efficient analysis.

Purpose of the Study:

  • To develop and validate an integrative data mining strategy for identifying and ranking candidate genes in inherited myopathies.
  • To aid in achieving molecular diagnoses for patients with undiagnosed myopathies.

Main Methods:

  • Utilized an integrative data mining strategy using the Manteia web-based system.
  • Extracted disease signatures from training gene sets based on functional annotations, phenotypes, pathways, and protein interactions.
  • Ranked candidate genes by filtering for skeletal muscle expression and known disease associations.

Main Results:

  • Identified and ranked candidate genes for inherited myopathies and related disorders.
  • Highlighted potential common pathological mechanisms and allelic disease groups.
  • Validated the approach by prioritizing recently discovered disease-associated genes (e.g., B3GALNT2, GMPPB, B3GNT1).

Conclusions:

  • The data mining strategy effectively identifies and ranks candidate genes for inherited myopathies, aiding in the analysis of high-throughput sequencing data.
  • This automated approach can generate updated candidate gene lists, facilitating molecular diagnosis and genetic research in rare neuromuscular disorders.